TW200724544A - A medicine for suppressing hypersensitivity - Google Patents

A medicine for suppressing hypersensitivity

Info

Publication number
TW200724544A
TW200724544A TW095124574A TW95124574A TW200724544A TW 200724544 A TW200724544 A TW 200724544A TW 095124574 A TW095124574 A TW 095124574A TW 95124574 A TW95124574 A TW 95124574A TW 200724544 A TW200724544 A TW 200724544A
Authority
TW
Taiwan
Prior art keywords
medicine
taxoid
suppressing
pharmaceutical composition
substituted phenyl
Prior art date
Application number
TW095124574A
Other languages
Chinese (zh)
Inventor
Takahide Nishi
Hiroshi Tsuchida
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200724544A publication Critical patent/TW200724544A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

The present invention provides a pharmaceutical composition for suppressing allergy induced by taxoid. The pharmaceutical composition for suppressing allergy induced by taxoid, which contains as the active component, a compound of the following fomula (I), [wherein, R1 represents a substituted phenyl group, R2 represents a halogen substituted phenyl group, G represents a group of the fomula >C-OH or >S<arrow right>O, n represents an integer of 1 or 2], or the pharmaceutically acceptable salt thereof.
TW095124574A 2005-07-07 2006-07-06 A medicine for suppressing hypersensitivity TW200724544A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005199217 2005-07-07

Publications (1)

Publication Number Publication Date
TW200724544A true TW200724544A (en) 2007-07-01

Family

ID=37637018

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095124574A TW200724544A (en) 2005-07-07 2006-07-06 A medicine for suppressing hypersensitivity

Country Status (2)

Country Link
TW (1) TW200724544A (en)
WO (1) WO2007007625A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3088672B2 (en) * 1995-12-01 2000-09-18 三共株式会社 Saturated heterocyclic compounds
JP2000034288A (en) * 1998-01-23 2000-02-02 Sankyo Co Ltd Spiropiperidine derivative

Also Published As

Publication number Publication date
WO2007007625A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
UA94833C2 (en) Substituted bicyclolactams
EP2041159B8 (en) Macrocyclic compounds as antiviral agents
MX2010009752A (en) Oxadiazoanthracene compounds for the treatment of diabetes.
TW200719886A (en) Dihydrobenzofuran derivatives and uses thereof
MX2009000884A (en) Pyridizinone derivatives.
CL2008003431A1 (en) 2 &#39;, 4&#39; substituted nucleoside derived compounds; process of preparation of said compounds; pharmaceutical composition comprising them; its method of preparation; and its use for the treatment and / or prevention of any condition resulting from an infection by hiv, hiv or hiv.
TW200718422A (en) 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
RS20090249A (en) Spiroketone acetyl-coa carboxylase inhibotors
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
EA200700566A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING LEVETRIACETES, AND METHODS OF THEIR RECEIVING
TW200637810A (en) Substituted N-aminomethylenesulfonamides, their preparation and use as medicaments
EA201100795A1 (en) PHARMACEUTICAL COMPOSITION OF EFFICIENT HSG INHIBITOR FOR ORAL ADMINISTRATION
MX2009007482A (en) Antiparasitic agents.
MY151986A (en) Adamantyl diamide derivatives and uses of same
WO2007120374A3 (en) Anti-arenaviral compounds
EA200970532A1 (en) FUMARATE SALT (ALPHA S, BETA R) -6-BRUM-ALPHA- [2- (DIMETHYLAMINO) ETHYL] -2-METHOXY-ALPHA-1-NAPHTHALENYL-BETA-PHENYL-3-HINOLINETHANOL
BRPI0414864A (en) multiparticulate pharmaceutical composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamide
WO2007038425A3 (en) Anti-viral compouinds
UY30778A1 (en) COMPOUNDS OF 5,6-DIHIDRO-1H-PIRIDIN-2-ONA
MX2021004474A (en) Compounds containing deuterium.
MX2021014680A (en) Benzotriazole derivative.
MX2009008028A (en) Benzofuran antiparasitic agents.
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
TW200745048A (en) Novel benzimidazole and benzothiazole derivatives, preparation process therefor, application thereof as medicaments, pharmaceutical compositions and novel use especially as CMET inhibitors